Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Check CapNeurometrixAdheriumCotinga Pharmaceuticals
SymbolNASDAQ:CHEKNASDAQ:NUROASX:ADRN/A
Price Information
Current Price$1.74$0.28A$0.05N/A
52 Week RangeBuyBuyN/AN/A
Analyst Ratings
Consensus RecommendationBuyBuyN/AN/A
Consensus Price Target$10.50$5.00N/AN/A
% Upside from Price Target503.45% upside1,662.43% upsideN/AN/A
Trade Information
Market CapN/A$2.92 million$8.70 millionC$2.86 million
BetaN/A0.54N/AN/A
Average VolumeN/A148,056N/A41,935
Sales & Book Value
Annual RevenueN/A$16.09 million$2.78 millionN/A
Price / SalesN/A0.173.13N/A
CashflowN/A$0.02 per shareA$0.06 per shareN/A
Price / CashN/A12.480.7812.50
Book Value$8.12 per share$0.79 per shareA$0.01 per shareC($0.11) per share
Price / BookN/A0.3610.00N/A
Profitability
Net Income$-10,590,000.00$20,000.00N/AN/A
EPS($2.61)N/AA($0.07)C($0.12)
Trailing P/E RatioN/A0.00N/AN/A
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/A
Net MarginsN/A-48.86%N/AN/A
Return on Equity (ROE)-83.70%-58.03%N/AN/A
Return on Assets (ROA)-72.16%-30.15%N/AN/A
Dividend
Annual PayoutN/AN/AN/AC$0.24
Dividend YieldN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/A
Current Ratio6.84%1.83%1.25%0.14%
Quick Ratio6.84%1.40%0.82%0.06%
Ownership Information
Institutional Ownership PercentageN/A16.91%N/AN/A
Insider Ownership PercentageN/A6.40%N/AN/A
Miscellaneous
Employees5642N/AN/A
Shares Outstanding1.60 million9.78 million174.03 million21.99 million
Next Earnings Date11/4/2019 (Estimated)1/23/2020 (Estimated)N/A10/21/2019 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableOptionable
 Check CapNeurometrixAdheriumCotinga Pharmaceuticals

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel